Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PMS-LOSARTAN-HCTZ | 12.5MG 100MG | TABLET | Resolved | 2017-09-19 | 2017-10-11 | 22785 |
PMS-LOSARTAN-HCTZ | 12.5MG 100MG | TABLET | Resolved | 2017-11-17 | 2018-02-22 | 29509 |
PMS-LOSARTAN-HCTZ | 12.5MG 100MG | TABLET | Resolved | 2018-02-06 | 2018-04-19 | 38917 |
PMS-LOSARTAN-HCTZ | 12.5MG 100MG | TABLET | Resolved | 2018-05-18 | 2019-06-29 | 49747 |
PMS-LOSARTAN-HCTZ | 12.5MG 100MG | TABLET | Resolved | 2019-08-01 | 2020-05-19 | 90536 |
PMS-LOSARTAN-HCTZ | 12.5MG 100MG | TABLET | Resolved | 2019-09-12 | 2020-05-19 | 93816 |
PMS-LOSARTAN-HCTZ | 25MG 100MG | TABLET | Resolved | 2018-11-29 | 2019-06-29 | 67937 |
PMS-LOSARTAN-HCTZ | 25MG 100MG | TABLET | Resolved | 2019-09-12 | 2020-02-04 | 93819 |
PMS-LOSARTAN-HCTZ | 25MG 100MG | TABLET | Resolved | 2021-11-15 | 2022-01-26 | 149230 |
CANDESARTAN-HCTZ | 12.5MG 16.0MG | TABLET | Resolved | 2019-05-16 | 2019-07-18 | 84241 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
RAMIPRIL-HCTZ | Discontinued | 2018-12-21 | 2018-12-22 | 70392 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 |